Cargando…
Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy
BACKGROUND: Little is known regarding the rate and clinical outcomes of asymptomatic carriers of SARS‐CoV‐2 among patients with cancer. Detection of asymptomatic carriers is important in this population given the use of myelosuppressive and immunomodulating therapies. Understanding the asymptomatic...
Autores principales: | Shaya, Justin, Cabal, Angelo, Nonato, Taylor, Torriani, Francesca, Califano, Joseph, Lippman, Scott, Sacco, Assuntina, McKay, Rana R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646446/ https://www.ncbi.nlm.nih.gov/pubmed/34708934 http://dx.doi.org/10.1002/cam4.4373 |
Ejemplares similares
-
Analysis of CDK12 alterations in a pan‐cancer database
por: Pan, Elizabeth, et al.
Publicado: (2021) -
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.
por: O'Byrne, K. J., et al.
Publicado: (1998) -
Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer
por: Fields, Emma C., et al.
Publicado: (2019) -
Weekly doxorubicin and continuous infusional 5-fluorouracil for advanced breast cancer.
por: Gabra, H., et al.
Publicado: (1996) -
Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer
por: Yekedüz, Emre, et al.
Publicado: (2023)